ERYTech Pharma SA Sponsored ADR Stock
ERYTech Pharma SA Sponsored ADR Stock price
Key metrics
| Market capitalization | $31.16m |
| Enterprise Value | $43.45m |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| P/B ratio (TTM) P/B ratio | 1.14 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-24.32m |
| Free Cash Flow (TTM) Free Cash Flow | $-23.25m |
| EPS (TTM) EPS | $-3.75 |
Is ERYTech Pharma SA Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
ERYTech Pharma SA Sponsored ADR Stock Analysis
Analyst Opinions
2 Analysts have issued a ERYTech Pharma SA Sponsored ADR forecast:
Analyst Opinions
2 Analysts have issued a ERYTech Pharma SA Sponsored ADR forecast:
Financial data from ERYTech Pharma SA Sponsored ADR
| Jun '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.91 -0.91 |
54%
54%
|
|
| EBITDA | -23 -23 |
15%
15%
|
EBIT (Operating Income) EBIT | -24 -24 |
9%
9%
|
| Net Profit | -24 -24 |
91%
91%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about ERYTech Pharma SA Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.
| Head office | France |
| CEO | Thibaut Fayet |
| Employees | 68 |
| Founded | 2004 |
| Website | www.phaxiam.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
